NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

AstraZeneca PLC AZN | NYSE

$157.14 -$0.56 | -0.36%
SIGNAL:Signal available — unlock to view |2026-10-01 |F&G 34 |RSI 40.5

Company Overview:

Market Cap: $244.59B
Trailing PE: 23.6x
FWD PE *: 14.7x
Payout Ratio (TTM): 47.0%
52-Week Range: $153.41 - $212.71

* Forward PE is based on street estimates.

10 Year AZN Performance Metrics:

Total Return (with DRIP): 216.4% (12.21% CAGR)
Total Return (no DRIP): 186.9% (11.12% CAGR)
Share Price: 145.1% (9.38% CAGR)
Yield on Cost (with DRIP): 4.27%
Total Invested: $10,000
Total Value (with DRIP): $31,642
Total Return $ (with DRIP): $21,642
Dividend Increase: 13.3% (1.33% CAGR)
Dividend Yield (FWD): 1.35% ($2.12)
AZN 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
AZN Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
AZN Price CAGR:1Y: -4.58%2Y: -0.57%5Y: 5.94%10Y: 9.38%
AZN Dividend Charts
AZN - Dividends
AZN Dividend CAGR:1Y: -50.77%2Y: 0.48%5Y: -11.66%10Y: -5.67%
AZN - Dividend Payout Ratio
AZN Dividend Payout Ratio CAGR:1Y: -35.63%2Y: -46.06%5Y: 0.00%10Y: 0.00%
AZN - Dividend to Free Cash Flow Ratio
AZN Dividend to FCF Ratio CAGR:1Y: -56.57%2Y: -35.04%5Y: -35.67%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

AZN Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

AZN - Revenue
AZN Revenue CAGR:1Y: 6.41%2Y: 9.04%5Y: 13.35%10Y: 10.63%
AZN - Earnings Per Share (EPS)
AZN EPS CAGR:1Y: 1.27%2Y: 13.24%5Y: 13.61%10Y: 0.00%
AZN - Net Income
🔓 See the full chart40% off right now · 7-day free trial
AZN Net Income CAGR:1Y: 2.33%2Y: 14.06%5Y: 35.44%10Y: 0.00%
AZN - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
AZN EBITDA CAGR:1Y: 4.20%2Y: 11.96%5Y: 22.88%10Y: 19.10%
AZN - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
AZN Free Cash Flow CAGR:1Y: 45.89%2Y: -6.03%5Y: 28.72%10Y: 0.00%
AZN - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
AZN Free Cash Flow / Share CAGR:1Y: 46.73%2Y: -5.64%5Y: 27.51%10Y: 0.00%
AZN - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
AZN Operating Income CAGR:1Y: -9.81%2Y: 7.34%5Y: 22.93%10Y: 26.44%
AZN - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
AZN Gross Profit CAGR:1Y: 7.32%2Y: 9.35%5Y: 16.36%10Y: 10.97%
AZN - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
AZN Shares Outstanding CAGR:1Y: 0.06%2Y: 41.42%5Y: 18.81%10Y: 9.45%
AZN - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
AZN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AZN - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
AZN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
AZN - Expenses
🔓 See the full chart40% off right now · 7-day free trial
AZN Expenses CAGR:1Y: -60.85%2Y: 6.16%5Y: 21.19%10Y: -2.81%
AZN - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
AZN - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
AZN - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
AZN - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
AZN - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
AZN - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
AZN - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
AZN Revenue CAGR:1Y: 6.41%2Y: 9.04%5Y: 13.35%10Y: 10.63%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

AZN - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
AZN Actual Revenue CAGR:1Y: 6.41%2Y: 9.04%5Y: 13.35%10Y: 10.63%
AZN - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
AZN Actual EPS CAGR:1Y: 1.27%2Y: 13.24%5Y: 13.61%10Y: 0.00%
AZN - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
AZN Actual Net Income CAGR:1Y: 2.33%2Y: 14.06%5Y: 35.44%10Y: 0.00%
AZN - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
AZN Actual EBITDA CAGR:1Y: 4.20%2Y: 11.96%5Y: 22.88%10Y: 19.10%

Ratios, Profit Margins & Return on Capital:

AZN - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
AZN Net Profit Margin CAGR:1Y: -3.83%2Y: 4.63%5Y: 19.50%10Y: 0.00%
AZN - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
AZN Gross Profit Margin CAGR:1Y: -2.16%2Y: -1.42%5Y: 1.39%10Y: -0.97%
AZN - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
AZN Price to Earnings CAGR:1Y: 36.21%2Y: -3.13%5Y: -16.62%10Y: 0.00%
AZN - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
AZN Price To Sales Ratio CAGR:1Y: 30.67%2Y: 0.87%5Y: -0.45%10Y: 3.52%
AZN - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
AZN Return on Capital Employed CAGR:1Y: -17.85%2Y: -1.45%5Y: 12.19%10Y: 19.69%
AZN - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
AZN Return on Invested Capital CAGR:1Y: -4.82%2Y: 3.87%5Y: 16.83%10Y: 17.79%

Compare stocks side-by-side

AZN Dividends Info:

Annual Dividend: $2.12
Forward Yield: 1.35%
Ex-Dividend Date: 2026-08-07
Lifetime Dividends / Share: $63.19

AZN Dividend History: Dates, Payments & Yield list

Below is a schedule of all AZN dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/07/202609/08/2026$1.0601.31%1.32%$160.04
02/20/202603/23/2026$2.1702.13%2.36%$184.07
02/19/202602/23/2026$2.1532.06%2.1%$204.94
08/08/202508/11/2025$0.5150.73%0.7%$146.12
02/21/202502/24/2025$1.0501.47%1.42%$148.01
08/09/202408/12/2024$0.5000.62%0.62%$160.71
02/22/202402/26/2024$0.9851.56%1.52%$129.99
08/10/202308/14/2023$0.4650.67%0.65%$143.20
02/23/202302/27/2023$0.9851.46%1.46%$135.32
08/11/202209/12/2022$0.9321.45%1.57%$118.91
02/24/202203/28/2022$1.9703.42%2.95%$133.43
08/12/202109/13/2021$0.8961.55%1.56%$114.89
02/25/202103/29/2021$1.9424.03%3.88%$100.00
08/13/202009/14/2020$0.9111.64%1.67%$108.90
02/27/202003/30/2020$1.8854.15%4.31%$87.37
08/08/201909/09/2019$0.8721.98%1.99%$87.60
02/28/201903/27/2019$1.9004.64%4.52%$84.02
08/09/201809/10/2018$0.9002.32%2.38%$75.50
02/15/201803/19/2018$1.9005.74%5.5%$69.14
08/09/201709/11/2017$0.9003.1%2.73%$65.98
02/15/201703/20/2017$1.9006.65%6.28%$60.50
08/10/201609/12/2016$0.9002.68%2.75%$65.37
02/17/201603/21/2016$1.9006.27%6.7%$56.70
08/12/201509/14/2015$0.9002.69%2.73%$65.90
02/18/201503/23/2015$1.9005.44%5.26%$72.25
08/13/201409/15/2014$0.9002.63%2.44%$73.78
02/19/201403/24/2014$1.9005.73%5.95%$63.91
08/14/201309/16/2013$0.9003.56%3.51%$51.31
02/13/201303/18/2013$1.9008.29%8.16%$46.55
08/08/201209/10/2012$0.9003.81%3.87%$46.55
02/15/201203/19/2012$1.9508.66%8.67%$45.00
08/04/201109/12/2011$0.8503.85%3.95%$43.05
02/02/201103/14/2011$1.8507.76%7.91%$46.80
08/04/201009/13/2010$0.7002.72%2.7%$51.84
02/03/201003/15/2010$1.7107.6%7.73%$44.25
08/05/200909/14/2009$0.5902.52%2.6%$45.40
02/04/200903/16/2009$1.5007.96%8.79%$34.13
08/06/200809/15/2008$0.5502.23%2.45%$44.94
02/07/200803/17/2008$1.3506.97%7.61%$35.50
08/08/200709/17/2007$0.5202.04%2.18%$47.75
02/07/200703/19/2007$1.2304.26%4.43%$55.47
08/09/200609/18/2006$0.4901.62%1.56%$62.79
02/08/200603/20/2006$0.9203.97%3.61%$50.90
08/10/200509/19/2005$0.3801.64%1.59%$47.80
02/09/200503/21/2005$0.6453.28%3.15%$40.89
08/11/200409/20/2004$0.2951.34%1.41%$41.70
02/18/200404/06/2004$0.5402.27%2.26%$47.83
08/20/200310/06/2003$0.2551.26%1.12%$45.53
02/19/200304/07/2003$0.5223.04%2.9%$36.01
08/21/200210/07/2002$0.2561.68%1.61%$31.68
02/20/200204/08/2002$0.5222.1%2.14%$48.80
08/22/200110/05/2001$0.2561.04%1.08%$47.45
02/21/200104/09/2001$0.5222.29%2.09%$49.95
11/14/200011/16/2000$1.0734.47%4.57%$46.94
09/06/200010/23/2000$0.2561.16%1.07%$47.81
03/08/200004/17/2000$0.5222.86%2.42%$43.13
09/08/199910/25/1999$0.2561.29%1.09%$46.75
04/07/199904/28/1999$0.4962.14%2.44%$40.63
09/16/199809/18/1998$0.2831.44%1.45%$39.00
03/18/199803/20/1998$0.5122.34%2.39%$42.81
09/17/199709/19/1997$0.2661.68%1.66%$32.15
03/19/199703/21/1997$0.4473.17%3.19%$28.04
09/20/199609/23/1996$0.2411.96%1.97%$24.38
03/22/199603/25/1996$0.2532.43%2.45%$20.67
09/22/199509/25/1995$0.2242.53%2.54%$17.63
03/24/199503/27/1995$0.3514.94%4.94%$14.21
09/23/199409/26/1994$0.2053.18%3.3%$12.46
03/18/199403/21/1994$0.3145.59%5.63%$11.17
09/24/199309/27/1993$0.1933.58%3.58%$10.79

Projected Future Returns & Dividends for AZN

Based on past 10-year performance, here are AZN growth metrics:

Share price CAGR of +9.38%
Dividend CAGR of +1.65%

Using AZN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

AZN (DRIP)AZN - No DRIP
Current Price$157.14$157.14
Start Shares63.6463.64
Start Value$10,000$10,000
  
After 10 years:
Final Share Count70.2563.64
Dividends Payment$1.25$1.25
Annual Dividends$175$159
Yield on cost1.75%1.59%
Share Price$385.17$385.17
Total Dividends$1,536$1,454
Final Value$27,060$25,965

Estimated Future Value + Dividends - AZN

NOTE: Above numbers are our estimate based on AZN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

AstraZeneca PLC (AZN) had its IPO on 1993-05-12, and is traded on NYSE stock exchange.

AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with primary and specialty care physicians worldwide, facilitating distribution through a robust network of representatives and local offices across the United Kingdom, continental Europe, the Americas, Asia, Africa, and Australasia. The firm actively drives innovation through strategic collaborations, partnering with entities such as Neurimmune AG for the development and commercialization of NI006, BenevolentAI for systemic lupus erythematosus drug discovery, Lunit for AI-powered digital pathology risk assessment in NSCLC, and Absci Corporation for AI-driven oncology target identification. Founded in 1992, the company was initially known as Zeneca Group PLC, subsequently rebranding to AstraZeneca PLC in April 1999, and maintains its headquarters in Cambridge, United Kingdom.

AZN website: https://www.astrazeneca.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — AZN

Value from:
Pay up to today
—
vs current price $157.14
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →